Search research articles
Contact Us
Filters
Showing results (91-100 of 94) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 94 results.
Cancer Prevention Research (Philadelphia, Pa.)
|
March 4, 2025
Evaluating Intermittent Dosing of Aspirin for Colorectal Cancer Chemoprevention
Xiangzhu Zhu, Ruohui Chen, Reid M Ness, et al.
Materials Horizons
|
May 26, 2026
Suppressing thermal transport in nonporous polymer hybrids by limiting thermally accessible vibrational modes
Henry Worden, Mihir Chandra, Yijie Zhou, et al.
JAMA Surgery
|
October 23, 2023
Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial
Seema A Khan, Xinlei Mi, Yanfei Xu, et al.
Frontiers in Immunology
|
June 4, 2026
Design and preliminary report of a randomized phase IIb clinical trial of multitargeted recombinant adenovirus 5 vaccines against CEA, MUC1, and brachyury (Tri-Ad5) and the IL-15 receptor superagonist nogapendekin alfa inbakicept in Lynch syndrome (TRIAD5-Plus): the first cross-network trial of the Cancer Prevention Clinical Trials Network (CP-CTNet)
Ajay Bansal, Elena M Stoffel, Ramona Lim, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 94) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 94 results.
Cancer Prevention Research (Philadelphia, Pa.)
|
March 4, 2025
Evaluating Intermittent Dosing of Aspirin for Colorectal Cancer Chemoprevention
Xiangzhu Zhu, Ruohui Chen, Reid M Ness, et al.
Materials Horizons
|
May 26, 2026
Suppressing thermal transport in nonporous polymer hybrids by limiting thermally accessible vibrational modes
Henry Worden, Mihir Chandra, Yijie Zhou, et al.
JAMA Surgery
|
October 23, 2023
Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial
Seema A Khan, Xinlei Mi, Yanfei Xu, et al.
Frontiers in Immunology
|
June 4, 2026
Design and preliminary report of a randomized phase IIb clinical trial of multitargeted recombinant adenovirus 5 vaccines against CEA, MUC1, and brachyury (Tri-Ad5) and the IL-15 receptor superagonist nogapendekin alfa inbakicept in Lynch syndrome (TRIAD5-Plus): the first cross-network trial of the Cancer Prevention Clinical Trials Network (CP-CTNet)
Ajay Bansal, Elena M Stoffel, Ramona Lim, et al.
Page
of 10